Region: South Korea

Samsung Electronics dominates Korea’s 2023 patent filings

LG Energy and Kia saw a significant surge in applications between 2019 and 2023

07 June 2024

A guide to ongoing biosimilar battles as Johnson & Johnson reaches Stelara settlement

IAM hones in on spats over several biologic drugs in Europe and beyond

08 April 2024

South Korea’s patent push could be fruitful if leveraged well

Saturday Opinion: KIPO claims the country is entering a so-called “pro-patent era” but businesses need to take the reins

09 March 2024

How to register AI patents in Asia-Pacific and Europe: the dos and don’ts

Legislation on AI and computer-implemented inventions varies widely from country to country. When it comes to prosecution, experts in Australia, China, South Korea and Europe offer some innovative pathways to patenting wins

04 March 2024

South Korea most likely to take the lead in lithium-ion battery race

As the global lithium-ion battery invention space continues to grow in portfolio size and strength, all eyes are on South Korean firms, which dominate the top 10 patent holders. According to analysis, the country is on the path to claiming the patent portfolio top spot from Japan in the coming years.

14 February 2024

‘The best way to predict the future is to invent it’: an interview with Korean R&D shop Wilus

The company is seeking to become the world’s go-to standards technology development company, says CEO Jin Sam Kwak

06 February 2024

South Korean office has ambitious plans for IP finance future

KIPO has pledged to increase the size of the country’s IP financing market and “lay the groundwork” for brand-backed financing

10 January 2024

South Korea: IP Office’s DABUS Nullification Highlights Stance Towards AI Inventors

Featured in The Patent Prosecution Review 2024

According to the Korean Patent Act, the right to obtain a patent is vested in a person who makes an invention or their successor. The Seoul Administrative Court’s decision to dismiss the DABUS appeal cements the IP office and the courts’ position on this matter.

08 December 2023

CRISPR-Cas9 drugmakers like Vertex should come to the table early, says ToolGen’s IP chief

Chief Legal Officer Yoori Kim argues that current patent uncertainty should fuel rather than thwart licensing deals

01 November 2023

Unitary Patents increasingly popular with Asian innovators

But European firms still dominate as the number of UPs requested passes the 8,000-mark

04 September 2023

Unlock unlimited access to all IAM content